Part
1. General Principles.-Physiology of Hemostasis.- Laboratory
Assessment of Physiologic and Pathologic Hemostasis.- Current Anticoagulation
Drugs and Mechanisms of Action.- Reversal of Target-Specific Oral
Anticoagulants.- Overview, Treatment, Measurement, and Modification of Platelet
Function.- Role of Antiplatelet Therapy in Neurosurgery: Efficacy and Safety
Profiles.- Part 2. Coagulation Issues
Across all Patient Spectrums.- Congenital Coagulation Disorders.- Acquired
Coagulation Disorders.- Regulation and Dysregulation of Fibrinolysis.- Risks
Associated with Administration of Allogeneic Blood Components.- Common
Coagulation Disorders That May Arise Intraoperatively.- Evaluation and
Management of Untoward Intraoperative Bleeding.- Treatment of Disseminated
Intravascular Coagulation (DIC).- Heparin-Induced Thrombocytopenia (HIT).- Anticoagulation
in Cardiovascular Diseases.- Workup and Treatment of Pulmonary Embolus .- Part
3. Coagulation Issues Specific to
Neurosurgery.- Classes of Drugs and Blood Products for Acute Reversal of
Anticoagulant Effect.- Rescue Strategies to Facilitate Emergency Neurosurgery in
Patients on Antiplatelet or Anticoagulant Agents.- Considerations for
Coagulation in the Multi‐Trauma Patient.- Cerebral Venous Sinus Thrombosis.- Coagulation
Studies in Preoperative Neurosurgery Patients.- Safe Strategies for Gradual
Suspension and Re-institution of Anticoagulation to Permit Elective Surgery.- Spontaneous
Intracerebral Hemorrhage due to Coagulation Disorders.- Prophylactic Screening
for Venous Thromboembolism in Neurosurgical Patients.- Venous Thromboembolism
Prophylaxis in Neurosurgery.- Can Patients with Known Intracranial and Intraspinal
Vascular Lesions be Anticoagulated?.- Intrathecal Access and Devices in
Patients on Antiplatelet or Anticoagulant Therapy.- Is it Safe to Shunt
Anti-coagulated NPH Patients?.- Surgical Hemostasis in the Era of
Anticoagulation: Guidelines and Recommendations Summary.
Christopher M. Loftus, MD, Dr.h.c., FACS, is Professor and Chairman, Department of Neurosurgery, and Professor of Neurology at Loyola University Stritch School of Medicine, Maywood, IL, USA. His previous appointments include Professor and Chairman, Department of Neurosurgery, Temple University School of Medicine, Philadelphia, PA; The Harry Wilkins Professor and Chairman and The Esther and Ted Greenberg Professor and Chairman, Department of Neurosurgery, The University of Oklahoma Health Sciences Center, Oklahoma City, OK; and Professor of Surgery (Neurosurgery), The University of Iowa College of Medicine, Iowa City, IA. Dr. Loftus is a Diplomate of the National Board of Medical Examiners and the American Board of Neurological Surgery. He has held many offices in leading professional bodies, including Vice Presidency of the American Association of Neurological Surgeons, and he is currently Treasurer of the World Federation of Neurosurgical Societies. His research interests include intracranial collateral circulation, extracranial carotid occlusive disease, and responses of cerebral blood flow to cerebral revascularization. He is participating in the IHAST cooperative trial for hypothermia in aneurysm surgery and the ISUIA - unruptured aneurysm trial. Dr. Loftus has been a member of the editorial boards of many prestigious journals and is the author of more than 200 articles and book chapters in peer-reviewed publications. He has edited or authored over twenty previous books, including, most recently, Intraoperative Neuromonitoring (McGraw-Hill, New York, 2013; co-editors Biller J and Baron EF).
This book is an up-to-date reference on all aspects of anticoagulation and hemostasis in neurosurgery. After an opening section on basic principles and drug classes in current use, detailed consideration is given to coagulation issues relevant to all patients, not just neurosurgical ones. The coverage includes, for example, deep vein thrombosis, pulmonary embolism, and disseminated intravascular coagulation. A variety of important issues specific to neurosurgical practice are then addressed, and the book concludes with a summary of current guidelines and best practices.
As the population ages and prophylactic anticoagulation for different cardiac disorders is validated by cooperative trials, it is becoming ever more important that practicing neurosurgeons have the requisite knowledge to manage optimally the opposing processes of anticoagulation and hemostasis. Nevertheless, only a modest amount of structured information is at present available on the subject, with the consequence that decision making is too often insufficiently informed. This book, written by recognized experts, is designed to rectify this situation by bringing together the latest knowledge from across the entire discipline. It will be of daily value for neurosurgeons and trainees worldwide and will also be of interest to emergency room physicians, surgeons in general, critical care physicians, neurologists, and hospital medicine specialists.